Search Results - Yijin Qiu
- Showing 1 - 1 results of 1
-
1
The Cost Effectiveness of Donafenib Compared With Sorafenib for the First-Line Treatment of Unresectable or Metastatic Hepatocellular Carcinoma in China by Rui Meng, Yingdan Cao, Ting Zhou, Hongfei Hu, Yijin Qiu
Published 2022Call Number: Loading…Connect to this object online.
Located: Loading…
Book